Direct-to-Consumer Testing 2.0: Emerging Models of Direct-to-Consumer Genetic Testing.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 29304915.
- Also identified by DOI 10.1016/j.mayocp.2017.11.001.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Direct-to-consumer (DTC) genetic testing emerged in the early 2000s as a means of allowing consumers to access information on their genetics without the involvement of a physician. Although early models of DTC were popular with consumers, they were controversial in medical and regulatory circles. In this article, we trace the history of DTC genetic testing, discuss its regulatory implications, and describe the emergence of a new hybrid model we call DTC 2.0.
Medical subject headings
- Computer-Assisted Instruction
- Direct-To-Consumer Screening and Testing
- Education, Medical, Continuing
- Genetic Testing